Announced Mon, 6 Jul · 19:38 IST
Routine filing of confirmation certificate for Q1 FY27
Compliance View source PDF
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹1913.60
prior close
₹1900.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.4+0.6+0.8-1.4+1.4+1.0+0.4+1.6+2.0————
Up moveDown movePending
AI summary
Sun Pharma has filed a routine compliance certificate with the stock exchanges. The certificate, submitted by its Registrar and Share Transfer Agent MUFG Intime, confirms that shares received for dematerialisation during the quarter ended 30 June 2026 were properly processed, confirmed or rejected to the depositories, and security certificates were cancelled within prescribed timelines. This is a standard SEBI regulatory filing required every quarter.
Likely market impact
No material impact on shareholders or stock price. Standard procedural compliance under SEBI rules.